A Randomized, Single-blind, Propofol-controlled Phase III Study Evaluating the Efficacy and Safety of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the Post-anesthesia Care Unit / Intensive Care Unit
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2017
At a glance
- Drugs Remimazolam (Primary) ; Propofol
- Indications Sedation
- Focus Therapeutic Use
- Sponsors PAION
- 09 Mar 2017 Trial has been completed in Germany (7 March 2016).
- 22 Mar 2016 Status changed from recruiting to discontinued due to poor recruitment as reported by ClinicalTrials.gov.
- 15 Jul 2015 New trial record